Susquehanna Fundamental Investments, LLC Siga Technologies Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.32 - $5.77 $11,460 - $15,307	-2,653 Reduced 20.0%	10,609 $55,000
Q2 2023 Aug 11, 2023	SELL	$5.0 - $6.31 $116,985 - $147,635	-23,397 Reduced 63.82%	13,262 $66,000
Q1 2023 May 16, 2023	SELL	$5.23 - $8.42 $22,060 - $35,515	-4,218 Reduced 10.32%	36,659 $210,000
Q4 2022 Feb 14, 2023	SELL	$7.29 - $10.14 $260,420 - $362,231	-35,723 Reduced 46.64%	40,877 $300,000
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $767,532 - $2 Million	76,600 New	76,600 $789,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $456M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.